Skip to main content
Top
Published in: International Journal of Clinical Oncology 6/2016

01-12-2016 | Original Article

Incidence and risk factors of synchronous colorectal cancer in patients with esophageal cancer: an analysis of 480 consecutive colonoscopies before surgery

Authors: Naoya Yoshida, Yuka Tamaoki, Yoshifumi Baba, Yasuo Sakamoto, Yuji Miyamoto, Masaaki Iwatsuki, Takashi Shono, Hideaki Miyamoto, Masanori Imuta, Junji Kurashige, Hiroshi Sawayama, Ryuma Tokunaga, Masayuki Watanabe, Yutaka Sasaki, Yasuyuki Yamashita, Hideo Baba

Published in: International Journal of Clinical Oncology | Issue 6/2016

Login to get access

Abstract

Background

The precise incidence rates of multiple primary colorectal cancers in esophageal cancer patients are unknown.

Methods

In total, 480 consecutive patients with esophageal cancers surgically resected in the Kumamoto University Hospital received preoperative total colonoscopy for the assessment of colorectal disease between April 2005 and February 2016. We retrospectively investigated the occurrence of synchronous colorectal cancer with esophageal cancer. In addition, we examined the risk factors for the incidence of multiple primary colorectal cancers.

Results

Of the 480 patients, 14 (2.9 %) had synchronous colorectal cancers, 13 had well-differentiated tubular adenocarcinomas, and 1 had papillary adenocarcinoma. Other 14 patients had metachronous colorectal cancer. The current incidence rates of synchronous and total (both synchronous and metachronous) colorectal cancers outnumbered those in normal healthy population and those in esophageal cancer patients which previously reported by The Japan Esophageal Society. The age ≥70 years (hazard ratio 4.82, 95 % confidence interval 1.473–15.78; p = 0.009) and Brinkman index ≥800 (hazard ratio 3.47, 95 % confidence interval 1.056–11.37; p = 0.040) were the independent risk factors for the incidence of synchronous colorectal cancer. They were also the independent risk factors for the incidence of total colorectal cancer.

Conclusions

The results of the present study suggested that pretreatment screening with total colonoscopy is meaningful for patients with esophageal cancer, because the frequency of synchronous colorectal cancer was not negligible. Particularly, in patients >70 years and with history of heavy smoking, pretreatment colonoscopy might be necessary.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nandy N, Dasanu CA (2013) Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review. Curr Med Res Opin 29:1055–1065CrossRefPubMed Nandy N, Dasanu CA (2013) Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review. Curr Med Res Opin 29:1055–1065CrossRefPubMed
2.
go back to reference Kagei K, Hosokawa M, Shirato H et al (2002) Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer. Jpn J Clin Oncol 32:120–127CrossRefPubMed Kagei K, Hosokawa M, Shirato H et al (2002) Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer. Jpn J Clin Oncol 32:120–127CrossRefPubMed
3.
go back to reference The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2009) Comprehensive Registry of Esophageal cancer in Japan, 2009. Editorial Office of The Japan Esophageal Society, Tokyo, pp 5–6 The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2009) Comprehensive Registry of Esophageal cancer in Japan, 2009. Editorial Office of The Japan Esophageal Society, Tokyo, pp 5–6
7.
go back to reference The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2005) Comprehensive registry of esophageal cancer in Japan, 2005. Editorial Office of The Japan Esophageal Society, Tokyo, p 7 The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2005) Comprehensive registry of esophageal cancer in Japan, 2005. Editorial Office of The Japan Esophageal Society, Tokyo, p 7
8.
go back to reference The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2006) Comprehensive registry of esophageal cancer in Japan, 2006. Editorial Office of The Japan Esophageal Society, Tokyo, p 7 The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2006) Comprehensive registry of esophageal cancer in Japan, 2006. Editorial Office of The Japan Esophageal Society, Tokyo, p 7
9.
go back to reference The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2007) Comprehensive registry of esophageal cancer in Japan, 2007. Editorial Office of The Japan Esophageal Society, Tokyo, p 7 The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2007) Comprehensive registry of esophageal cancer in Japan, 2007. Editorial Office of The Japan Esophageal Society, Tokyo, p 7
10.
go back to reference The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2008) Comprehensive registry of esophageal cancer in Japan, 2008. Editorial Office of The Japan Esophageal Society, Tokyo, p 7 The Registration Committee for Esophageal Cancer, The Japan Esophageal Society (2008) Comprehensive registry of esophageal cancer in Japan, 2008. Editorial Office of The Japan Esophageal Society, Tokyo, p 7
11.
go back to reference The Japan Esophageal Society (2012) Guidelines for the diagnosis and treatment of esophageal cancer, 2012. Kanahara-shuppan, Tokyo, p 8 The Japan Esophageal Society (2012) Guidelines for the diagnosis and treatment of esophageal cancer, 2012. Kanahara-shuppan, Tokyo, p 8
12.
go back to reference Steevens J, Schouten LJ, Goldbohm RA et al (2010) Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 59:39–48CrossRefPubMed Steevens J, Schouten LJ, Goldbohm RA et al (2010) Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 59:39–48CrossRefPubMed
13.
go back to reference Ishiguro S, Sasazuki S, Inoue M, JPHC Study Group et al (2009) Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study). Cancer Lett 275:240–246CrossRefPubMed Ishiguro S, Sasazuki S, Inoue M, JPHC Study Group et al (2009) Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study). Cancer Lett 275:240–246CrossRefPubMed
14.
go back to reference Cho E, Smith-Warner SA, Ritz J et al (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140:603–613CrossRefPubMed Cho E, Smith-Warner SA, Ritz J et al (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140:603–613CrossRefPubMed
15.
go back to reference Botteri E, Iodice S, Bagnardi V et al (2008) Smoking and colorectal cancer: a meta-analysis. JAMA 300:2765–2778CrossRefPubMed Botteri E, Iodice S, Bagnardi V et al (2008) Smoking and colorectal cancer: a meta-analysis. JAMA 300:2765–2778CrossRefPubMed
16.
go back to reference Liu J, Wang J, Leng Y et al (2013) Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer 133:473–485CrossRefPubMed Liu J, Wang J, Leng Y et al (2013) Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer 133:473–485CrossRefPubMed
17.
go back to reference Bradbury KE, Appleby PN, Key TJ (2014) Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr 100(Suppl 1):394S–398SCrossRefPubMed Bradbury KE, Appleby PN, Key TJ (2014) Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr 100(Suppl 1):394S–398SCrossRefPubMed
18.
go back to reference Baba Y, Ishimoto T, Kurashige J et al (2016) Epigenetic field cancerization in gastrointestinal cancers. Cancer Lett 375:360–366CrossRefPubMed Baba Y, Ishimoto T, Kurashige J et al (2016) Epigenetic field cancerization in gastrointestinal cancers. Cancer Lett 375:360–366CrossRefPubMed
19.
go back to reference Greene CL, DeMeester SR, Augustin F et al (2014) Long-term quality of life and alimentary satisfaction after esophagectomy with colon interposition. Ann Thorac Surg 98:1713–1719CrossRefPubMed Greene CL, DeMeester SR, Augustin F et al (2014) Long-term quality of life and alimentary satisfaction after esophagectomy with colon interposition. Ann Thorac Surg 98:1713–1719CrossRefPubMed
20.
go back to reference Mine S, Udagawa H, Tsutsumi K et al (2009) Colon interposition after esophagectomy with extended lymphadenectomy for esophageal cancer. Ann Thorac Surg 88:1647–1653CrossRefPubMed Mine S, Udagawa H, Tsutsumi K et al (2009) Colon interposition after esophagectomy with extended lymphadenectomy for esophageal cancer. Ann Thorac Surg 88:1647–1653CrossRefPubMed
21.
go back to reference Miyazaki T, Tanaka N, Sano A et al (2013) Clinical significance of total colonoscopy for screening of colon lesions in patients with esophageal cancer. Anticancer Res 33:5113–5117PubMed Miyazaki T, Tanaka N, Sano A et al (2013) Clinical significance of total colonoscopy for screening of colon lesions in patients with esophageal cancer. Anticancer Res 33:5113–5117PubMed
22.
go back to reference Takeuchi D, Koide N, Komatsu D et al (2015) Prevalence and management of colorectal neoplasia in surgically treated esophageal cancer patients. Int J Surg 17:60–66CrossRefPubMed Takeuchi D, Koide N, Komatsu D et al (2015) Prevalence and management of colorectal neoplasia in surgically treated esophageal cancer patients. Int J Surg 17:60–66CrossRefPubMed
23.
go back to reference The Japan Society for Cancer of the Colon and Rectum (2014) Guidelines 2014 for the treatment of colorectal cancer. Kanahara-shuppan, Tokyo, p 43 The Japan Society for Cancer of the Colon and Rectum (2014) Guidelines 2014 for the treatment of colorectal cancer. Kanahara-shuppan, Tokyo, p 43
24.
go back to reference Lambert R, Sauvaget C, Sankaranarayanan R (2009) Mass screening for colorectal cancer is not justified in most developing countries. Int J Cancer 125:253–256CrossRefPubMed Lambert R, Sauvaget C, Sankaranarayanan R (2009) Mass screening for colorectal cancer is not justified in most developing countries. Int J Cancer 125:253–256CrossRefPubMed
25.
go back to reference Matsuda T, Marugame T, Kamo K, Japan Cancer Surveillance Research Group et al (2012) Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 42:139–147CrossRefPubMed Matsuda T, Marugame T, Kamo K, Japan Cancer Surveillance Research Group et al (2012) Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 42:139–147CrossRefPubMed
26.
go back to reference Noreen F, Röösli M, Gaj P et al (2014) Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle. J Natl Cancer Inst 106 Noreen F, Röösli M, Gaj P et al (2014) Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle. J Natl Cancer Inst 106
28.
go back to reference De Carvalho DD, Sharma S, You JS et al (2012) DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell 21:655–667CrossRefPubMedPubMedCentral De Carvalho DD, Sharma S, You JS et al (2012) DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell 21:655–667CrossRefPubMedPubMedCentral
30.
go back to reference Strul H, Kariv R, Leshno M et al (2006) The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol 101:255–262CrossRefPubMed Strul H, Kariv R, Leshno M et al (2006) The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol 101:255–262CrossRefPubMed
31.
go back to reference Ben Q, An W, Jiang Y et al (2012) Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142:762–772CrossRefPubMed Ben Q, An W, Jiang Y et al (2012) Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142:762–772CrossRefPubMed
32.
go back to reference Klarich DS, Brasser SM, Hong MY (2015) Moderate alcohol consumption and colorectal cancer risk. Alcohol Clin Exp Res 39(8):1280–1291CrossRefPubMed Klarich DS, Brasser SM, Hong MY (2015) Moderate alcohol consumption and colorectal cancer risk. Alcohol Clin Exp Res 39(8):1280–1291CrossRefPubMed
33.
go back to reference Aldridge AJ, Simson JN (2001) Histological assessment of colorectal adenomas by size. Are polyps less than 10 mm in size clinically important? Eur J Surg 167:777–781CrossRefPubMed Aldridge AJ, Simson JN (2001) Histological assessment of colorectal adenomas by size. Are polyps less than 10 mm in size clinically important? Eur J Surg 167:777–781CrossRefPubMed
34.
go back to reference Wong R, Walker-Dilks C, Raifu A (2012) Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer. Clin Oncol (R Coll Radiol) 24:86–104CrossRef Wong R, Walker-Dilks C, Raifu A (2012) Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer. Clin Oncol (R Coll Radiol) 24:86–104CrossRef
35.
go back to reference Chen SH, Chan SC, Chao YK et al (2013) Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan. PLoS One 8:e82812CrossRefPubMedPubMedCentral Chen SH, Chan SC, Chao YK et al (2013) Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan. PLoS One 8:e82812CrossRefPubMedPubMedCentral
Metadata
Title
Incidence and risk factors of synchronous colorectal cancer in patients with esophageal cancer: an analysis of 480 consecutive colonoscopies before surgery
Authors
Naoya Yoshida
Yuka Tamaoki
Yoshifumi Baba
Yasuo Sakamoto
Yuji Miyamoto
Masaaki Iwatsuki
Takashi Shono
Hideaki Miyamoto
Masanori Imuta
Junji Kurashige
Hiroshi Sawayama
Ryuma Tokunaga
Masayuki Watanabe
Yutaka Sasaki
Yasuyuki Yamashita
Hideo Baba
Publication date
01-12-2016
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 6/2016
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-016-1015-8

Other articles of this Issue 6/2016

International Journal of Clinical Oncology 6/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine